Human papillomavirus infection in relation to mild dyskaryosis in conventional cervical cytology

Purpose of investigation: To establish the prevalence and distribution of high-risk human papillomavirus (HPV) genotypes in Slovene women with repeat mild dyskaryosis, and to evaluate three molecular methods for the detection of HPV that could be used as a complementary method to cervical cytology.

Methods: In this prospective study 148 women with three subsequent cervical cytologic tests within two years showing mild dyskaryosis were enrolled. HPV infection was determined using three molecular tests: Hybrid Capture II and two variants of polymerase chain reaction (PCR-PGMY11/PGMY09 and PCR-CPI/CPIIG).

Results: HPV was detected in 17 of the 45 women aged < or =30 years and in 21 of the 103 women aged >30 years (37.8% vs 20.4%, p = 0.04). The most common genotype was HPV 16 detected in eight (21.1%) women, the next were HPV 53 and HPV 51, each detected in five (13.2 %) women. The three molecular methods matched in 92.9%.

Conclusion: Low prevalence of HPV infections indicates that cervical screening programmes in Slovenia are overburdened with mild dyskaryosis. Repeat cytology is not reliable; HPV testing might be useful as a complementary method.

Human papillomavirus; Mild dyskaryosis; Cervical cancer

[1] Nobbenhuis M.A.E., Walboomers J.M., Helmerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K. et al.: "Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study". Lancet, 1999, 354, 20.

[2] Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D. et al.: "Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review". Ann. Intern. Med., 2000, 132, 810.

[3] Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I et al.: "HPV testing in primary screening of older women". Br. J. Cancer, 1999, 81, 554.

[4] Schiffman M., Herrero R.，压ldesheim A., Sherman M.E., BrattI M., Wacholder S. et al.: "HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica". JAMA, 2000, 283, 87.

[5] Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J. et al.: "International trends in incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas". Int. J. Cancer., 1998, 75, 536.

[6] Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J. et al.: "International trends in incidence of cervical cancer: II. Squamous-cell carcinoma". Int. J. Cancer., 2000, 86, 429.

[7] Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh Ngai J., Kurman R.J. et aL:"Identifyinls women with cervical neo plasia: using human papillomavirus DNA testing for equivoca:l Papanicolaou results". JAMA, 1999, 281, 1605.

[8] Bergeron C., Jeanne! D., Poveda J., Cassonnet P., Orth G "Human pap仆lomavirus testing in women with mild cytologic atypia". Obstet. Gynecol., 2000, 95, 821.

[9] Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D. et al.: "Management of women who test positive for high-risk types of human papillomavirus: the HART study" Lancet, 2003, 362, 1871.

[10] Poljak M., Seme K.: "Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzymelinked immunosorbent assay". J. ViroL Methods., 1996, 56, 231.

[11] Munoz N., Bosch F.X., de Sanjose S., Herrero R., Casstellsague X., Shah K.V. et al.: International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer". N Engl. J. Med., 2003, 348, 518.

[12] Franco E., Monsonego J.: "New developments in cervical cancer screening and prevention". Oxford, Blackwell Science Ltd, 1997.

[13] Wright T.C. Jr., Lorincz A., Ferris D.G., Richart R.M., Ferenczy A., Mielzynska I. et al.: "Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears". Am. J. Obstet. Gynecol., 1998, 178, 962.

[14] Sherman M.E., Schiffman M., Cox J.T.: "Atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study group: Effects of age and human papilloma viral load on colposcopy triage data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS)". J. Natl. Cancer. Inst. 2002, 94, 102.

[15] Monsonego J.: "Global challenges of cervical cancer prevention" Eur. J. Gynaecol. Oneal., 2000, 21, 533.

[16] Arnold K.: "Guidelines for abnormal Pap tests: Do physicians follow them?". J. Natl. Cancer. Inst., 2002, 94, 880.

[17] Mandelblatt J.S., Lawrence W.F., Womack S.M., Jacobson D., Yi B., Hwang Y.T. et al.: "Benefits and costs of using HPV testing to screen for cervical cancer". JAMA, 2002, 287, 2372.

[18] Kim J.J., Wright T.C., Goldie S.J.: "Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance". JAMA, 2002, 287, 2382.

[19] "Cancer Incidence in Slovenia 2000". Report No 42, Ljubljana: 2003.

[20] Tachezy R., Hamsikova E., Hajek T., Mikyskova I., Smahel M., Van Ranst M. et al.: "Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with anti bodies against HPV 16, 18 and 33 virus-like particles". J. Med Viral., 1999, 58, 378.

[21] Chan P.K., Li W.H., Chan M.Y., Ma W.L., Cheung J.L., Cheng A.C.: "High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions". J. Med. Viral., 1999, 59, 232.

[22] Liaw K.L., Glass A.G., Manos M.M., Greer C.E., Scott D.R., Sherman M. et al.: "Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions". J. Natl. Cancer. Inst., 1999, 91, 954.

[23] Bosch F.X.: "The use of HPV typing in epidemiological research". Presented at the Eurogin 2003, 5"'International Multidisciplinary Congress: Preventing and Controlling Cervical Cancer in the New Millennium" (abstract PS7-2a). April 13-16, 2003.